Side-by-side comparison
Boston Scientific vs Edwards Lifesciences
As of Sep 25, 2026, P/E is 17.8x for Boston Scientific vs 50.2x for Edwards Lifesciences; P/S is 3.0x for Boston Scientific vs 7.6x for Edwards Lifesciences; revenue growth is 13.5% for Boston Scientific vs 14.6% for Edwards Lifesciences; operating margin is 19.8% for Boston Scientific vs 22.3% for Edwards Lifesciences.
Key metrics
| Metric | BSX | EW |
|---|---|---|
| Price | $43.92 | $86.29 |
| Market cap | $63.65B | $49.74B |
| P/E | 17.8x (#1) | 50.2x (#2) |
| P/S | 3.0x (#1) | 7.6x (#2) |
| Revenue growth | 13.5% (#2) | 14.6% (#1) |
| Operating margin | 19.8% (#2) | 22.3% (#1) |
| Net margin | 17.5% (#1) | 15.4% (#2) |
| Debt / equity | 0.44 (#2) | 0.06 (#1) |
| 1-year return | -55.3% (#2) | +13.2% (#1) |
| Research score | 53/100 (#2) | 63/100 (#1) |
Higher is better for growth, margins, one-year return and overall score; lower is better for valuation and debt ratios. Ties share a rank and missing values are excluded.
Company research
- Boston Scientific Corporation (BSX) — Medical Devices
- Edwards Lifesciences Corporation (EW) — Medical Devices